PMID: 32738492DOI: 10.1016/j.ijid.2020.07.057Aug 2, 2020Paper

Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19"

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
J Graham Atkinson
Get PDF

Abstract

No abstract listed.

Citations

Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review

Jun 11, 2020·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Tejas K PatelHira Lal Bhalla

A 21st Century Evil: Immunopathology and New Therapies of COVID-19

Nov 17, 2020·Frontiers in Immunology·Taylon Felipe SilvaMilena Menegazzo Miranda-Sapla

Beta-Adrenergic Receptor Stimulation Modulates the Cellular Proarrhythmic Effects of Chloroquine and Azithromycin.

Nov 17, 2020·Frontiers in Physiology·Henry Sutanto, Jordi Heijman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Hydroxychloroquine and azithromycin as a treatment of COVID-19.

(opens in new tab)
Internal and Emergency Medicine
Alice FaninGruppo di Autoformazione Metodologica (GrAM)

Hydroxychloroquine with or without Azithromycin in Covid-19.

(opens in new tab)
The New England Journal of Medicine
Rahul ChoudharyDeepak Kumar
ContactHelpTerms Privacy Cookies
© 2022 Meta ULC. All rights reserved